Sale!

NECAP1 Gene Early infantile epileptic encephalopathy type 21 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NECAP1 gene is associated with a rare neurological condition known as Early Infantile Epileptic Encephalopathy Type 21 (EIEE21). This condition is characterized by severe seizures that begin in the first few months of life, along with developmental delays and other possible neurological abnormalities. The NECAP1 gene plays a crucial role in brain development and function, and mutations in this gene can lead to the symptoms observed in EIEE21.

To diagnose this condition, a genetic test targeting the NECAP1 gene can be performed. This test is crucial for confirming the diagnosis, understanding the condition’s progression, and aiding in the management and treatment planning for affected individuals. It involves analyzing the DNA to identify mutations in the NECAP1 gene that are known to cause EIEE21.

In the United Arab Emirates, this specific genetic test can be conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the NECAP1 gene test for Early Infantile Epileptic Encephalopathy Type 21 is 4400 AED. This test is significant for families with a history of the condition or for infants showing symptoms associated with EIEE21, as it provides a definitive diagnosis and can guide further medical and therapeutic interventions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NECAP1 Gene Early infantile epileptic encephalopathy type 21 Genetic Test

Components:

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for NECAP1 Gene Early infantile epileptic encephalopathy type 21 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with NECAP1 Gene Early infantile epileptic encephalopathy type 21

Test Details:

The NECAP1 gene is associated with Early Infantile Epileptic Encephalopathy Type 21 (EIEE21), which is a rare genetic disorder characterized by seizures that begin in the first few months of life. This disorder can cause developmental delays, intellectual disability, and other neurological problems.

NGS (Next Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a person’s genetic makeup. This type of testing can help identify genetic mutations that may be causing a particular disorder or condition, such as EIEE21 caused by mutations in the NECAP1 gene.

NGS genetic testing for the NECAP1 gene can help diagnose EIEE21 in infants and young children who are experiencing seizures and other symptoms associated with the disorder. Early diagnosis can help parents and healthcare providers develop a treatment plan that may improve outcomes for affected children.

Test Name NECAP1 Gene Early infantile epileptic encephalopathy type 21 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NECAP1 Gene Early infantile epileptic encephalopathy type 21 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NECAP1 Gene Early infantile epileptic encephalopathy type 21
Test Details

The NECAP1 gene is associated with Early Infantile Epileptic Encephalopathy Type 21 (EIEE21), which is a rare genetic disorder characterized by seizures that begin in the first few months of life. This disorder can cause developmental delays, intellectual disability, and other neurological problems.

NGS (Next Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a person’s genetic makeup. This type of testing can help identify genetic mutations that may be causing a particular disorder or condition, such as EIEE21 caused by mutations in the NECAP1 gene.

NGS genetic testing for the NECAP1 gene can help diagnose EIEE21 in infants and young children who are experiencing seizures and other symptoms associated with the disorder. Early diagnosis can help parents and healthcare providers develop a treatment plan that may improve outcomes for affected children.